Systematic Financial Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,255	Closed	-$349K	–	259
2020 Q2	$349K	Sell	9,255 -1,535	-14%	-$50.6K	0.02%	204
2020 Q1	$312K	Sell	10,790 -590	-5%	-$23.9K	0.02%	301
2019 Q4	$590K	Buy	11,380 +1,495	+15%	+$86.8K	0.02%	367
2019 Q3	$543K	Sell	9,885 -13,275	-57%	-$682K	0.02%	342
2019 Q2	$941K	Sell	23,160 -12,450	-35%	-$454K	0.04%	325
2019 Q1	$1.08M	Sell	35,610 -1,875	-5%	-$64.2K	0.04%	473
2018 Q4	$1.26M	Buy	+37,485	New	+$1.35M	0.04%	287
2016 Q4	–	Sell	-50,200	Closed	-$2.4M	–	632
2016 Q3	$2.4M	Sell	50,200 -21,559	-30%	-$1.06M	0.03%	324
2016 Q2	$3.85M	Buy	71,759 +34,640	+93%	+$1.63M	0.05%	283
2016 Q1	$1.66M	Sell	37,119 -4,105	-10%	-$167K	0.02%	433
2015 Q4	$1.57M	Sell	41,224 -18,640	-31%	-$713K	0.02%	484
2015 Q3	$1.91M	Sell	59,864 -16,110	-21%	-$562K	0.02%	518
2015 Q2	$2.51M	Buy	+75,974	New	+$2.71M	0.02%	435
2014 Q3	–	Sell	-48,300	Closed	-$2.24M	–	675
2014 Q2	$2.24M	Sell	48,300 -592,827	-92%	-$26.4M	0.02%	393
2014 Q1	$26.4M	Buy	641,127 +509,187	+386%	+$18.9M	0.18%	139
2013 Q4	$5.03M	Buy	131,940 +68,770	+109%	+$2.12M	0.04%	334
2013 Q3	$1.51M	Buy	+63,170	New	+$1.42M	0.01%	462